STABLEPHARMA LIMITED

Active Bristol

Manufacture of basic pharmaceutical products

7 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
S

STABLEPHARMA LIMITED

Manufacture of basic pharmaceutical products

Founded 26 Jan 2012 Active Bristol, England 7 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 2 Sept 2025 Next due 31 Oct 2026 5 months remaining
Confirmation Submitted 11 Jul 2025 Next due 12 Jul 2026 2 months remaining
Net assets £4M £537K 2023 year on year
Total assets £4M £415K 2023 year on year
Total Liabilities £277K £122K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Ground Floor, 90 Victoria Street Bristol BS1 6DP England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for STABLEPHARMA LIMITED (07925414), an active life sciences and medical technology company based in Bristol, England. Incorporated 26 Jan 2012. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

£2.47M

Decreased by £1.04M (-30%)

Net Assets

£3.97M

Decreased by £536.82k (-12%)

Total Liabilities

£276.86k

Increased by £122.02k (+79%)

Turnover

N/A

Employees

7

Decreased by 1 (-13%)

Debt Ratio

7%

Increased by 4 (+133%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 2

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 5Jun 2019Series A, Seed
Investor 6Sept 2021Series A
Investor 3Dec 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

339 Allotments 45,747,267 Shares £138.51m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Dec 202468,632£28k£0.414
13 Dec 202442,291£18k£0.414
13 Dec 20245,437£2k£0.414
13 Dec 202424,166£10k£0.414
13 Dec 202418,125£7k£0.414

Officers

Officers

2 active 1 resigned
Status
Neil MayallSecretaryUnknownUnknown26 Jan 2023Active
Steven Neville ChatfieldDirectorBritishUnited Kingdom691 Nov 2024Active

Shareholders

Shareholders (172)

Bruce Joseph Roser
21.2%
21,149,543
Nicholas Edward Child
8.4%
8,403,465

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Bruce Joseph Roser

Ceased 30 Nov 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026CapitalAllotment of shares (GBP 10,368.6371) on 2 Feb 2026
29 Apr 2026CapitalAllotment of shares (GBP 10,370.5171) on 26 Feb 2026
29 Apr 2026CapitalAllotment of shares (GBP 10,332.2828) on 4 Nov 2025
24 Mar 2026OfficersAppointment of Karen O'hanlon as director on 1 Feb 2026
8 Jan 2026OfficersChange to director Mr Ozgur Tuncer on 7 Jan 2026
29 Apr 2026 Capital

Allotment of shares (GBP 10,368.6371) on 2 Feb 2026

29 Apr 2026 Capital

Allotment of shares (GBP 10,370.5171) on 26 Feb 2026

29 Apr 2026 Capital

Allotment of shares (GBP 10,332.2828) on 4 Nov 2025

24 Mar 2026 Officers

Appointment of Karen O'hanlon as director on 1 Feb 2026

8 Jan 2026 Officers

Change to director Mr Ozgur Tuncer on 7 Jan 2026

Recent Activity

Latest Activity

Allotment of shares (GBP 10,368.6371) on 2 Feb 2026

1 weeks ago on 29 Apr 2026

Allotment of shares (GBP 10,370.5171) on 26 Feb 2026

1 weeks ago on 29 Apr 2026

Allotment of shares (GBP 10,332.2828) on 4 Nov 2025

1 weeks ago on 29 Apr 2026

Appointment of Karen O'hanlon as director on 1 Feb 2026

1 months ago on 24 Mar 2026

Change to director Mr Ozgur Tuncer on 7 Jan 2026

4 months ago on 8 Jan 2026